Black mothers are faced with a disproportionate number of barriers to breastfeeding compared to other racial and ethnic groups.
A case of employment termination of a physician assistant (PA) who had a decade’s old contract with her employer. Was the ...
GSK has made the decision to withdraw Jesduvroq (daprodustat) from the US market. Approved in 2023, Jesduvroq, (HIF-PHI), is ...
The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of hepatotoxicity, following the Food and Drug Administration’s review of a ...
Significant changes from previous guideline include recommendation that only FSH >25 IU required for POI diagnosis.
Black mothers are faced with a disproportionate number of barriers to breastfeeding compared to other racial and ethnic groups.
Electronic sepsis screening among hospitalized ward patients reduces 90-day in-hospital mortality compared with no screening, according to a study published onl ...
The Food and Drug Administration (FDA) has approved Steqeyma ® (ustekinumab-stba), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases in adults and ...
Supplementation with cholecalciferol 1,000 IU/day during pregnancy is associated with greater offspring bone mineral density during childhood.